tiprankstipranks
BNYMC Ups Stake in Alterity Therapeutics
Company Announcements

BNYMC Ups Stake in Alterity Therapeutics

Alterity Therapeutics Ltd. (AU:ATH) has released an update.

Alterity Therapeutics Limited reports a change in substantial holding by The Bank of New York Mellon Corporation (BNYMC), with an increase in voting power from 38.52% to 39.55%. This shift occurred on May 1st, 2024, marking a notable change in the company’s shareholder structure. The update follows the previous notice provided a couple of weeks prior, reflecting the evolving interests of one of its significant investors.

For further insights into AU:ATH stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyBiotech Alert: Searches spiking for these stocks today
TipRanks Australian Auto-Generated NewsdeskAlterity Therapeutics Seeks ASX Quotation
TipRanks Australian Auto-Generated NewsdeskAlterity Therapeutics Plans New Share Issue
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!